Novonesis
(OTCPK:NVZMY)
$60.31
0[0.00%]
At close: May 8

Novonesis Stock (OTC:NVZMY), Quotes and News Summary

Novonesis Stock (OTC: NVZMY) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 16.757K
Day Range- - -
52 Wk Range38.750 - 61.860
Market Cap$28.005B
P/E Ratio38.401
Dividend Yield1.460%
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NVZMY

FAQ

Q

How do I buy Novonesis (NVZMY) stock?

A

You can purchase shares of Novonesis (OTCPK: NVZMY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novonesis's (NVZMY) competitors?

A

There are no as such competitors for Novonesis.

Q

What is the target price for Novonesis (NVZMY) stock?

A

The latest price target for Novonesis (OTCPK: NVZMY) was reported by Jefferies on Friday, August 7, 2015. The analyst firm set a price target for 44.45 expecting NVZMY to fall to within 12 months (a possible -26.30% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Novonesis (NVZMY)?

A

The stock price for Novonesis (OTCPK: NVZMY) is $60.31 last updated May 8, 2024 at 3:57 PM EDT.

Q

Does Novonesis (NVZMY) pay a dividend?

A

A quarterly cash dividend of $0.45 per share of Class A Common Stock. The quarterly cash dividend was payable on March 17, 2015 to stockholders of record on March 3, 2015.

Q

When is Novonesis (OTCPK:NVZMY) reporting earnings?

A

Novonesis’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Q

Is Novonesis (NVZMY) going to split?

A

There is no upcoming split for Novonesis.

Q

What sector and industry does Novonesis (NVZMY) operate in?

A

Novonesis is in the Materials sector and Chemicals industry. They are listed on the OTCPK.